Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Detailed comparison on NAV, returns, risk, holdings and cost
Growth of each fund's NAV over the selected period, rebased to 0%
Trailing risk-adjusted performance measures
|
|
| 3.32% |
| Name | Assets |
|---|---|
 Laurus Labs LtdEquity | 11.23% |
| Lupin LtdEquity | 8.01% |
 Aurobindo Pharma LtdEquity | 7.16% |
 Fortis Healthcare LtdEquity | 7.12% |
 Glenmark Pharmaceut...Equity | 5.63% |
| Alkem Laboratories LtdEquity | 4.70% |
 Biocon LtdEquity | 4.43% |
 Ipca Laboratories LtdEquity | 4.13% |
 Mankind Pharma LtdEquity | 4.11% |
| Gland Pharma LtdEquity | 3.46% |
| , , |
| Managing Since | 20 Dec 2024 | 28 Oct 2024 |
|---|
Growth of each fund's NAV over the selected period, rebased to 0%
